BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9918936)

  • 1. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Virology; 1998 Nov; 251(1):85-95. PubMed ID: 9813205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
    J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis.
    Reaiche GY; Le Mire MF; Mason WS; Jilbert AR
    Virology; 2010 Oct; 406(2):286-92. PubMed ID: 20705309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
    Jilbert AR; Miller DS; Scougall CA; Turnbull H; Burrell CJ
    Virology; 1996 Dec; 226(2):338-45. PubMed ID: 8955053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral effects of PNA in duck hepatitis B virus infection model.
    Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
    Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
    Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
    Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
    Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver.
    Reaiche-Miller GY; Thorpe M; Low HC; Qiao Q; Scougall CA; Mason WS; Litwin S; Jilbert AR
    Virology; 2013 Nov; 446(1-2):357-64. PubMed ID: 24074600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression.
    Luscombe C; Pedersen J; Uren E; Locarnini S
    Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
    Schorr O; Borel C; Trepo C; Zoulim F; Hantz O
    J Hepatol; 2006 May; 44(5):842-7. PubMed ID: 16458387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure.
    Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L
    Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.
    Borel C; Sunyach C; Hantz O; Trepo C; Kay A
    Virology; 1998 Mar; 242(1):90-8. PubMed ID: 9501048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of spontaneous mutations in an avian hepadnavirus infection.
    Pult I; Abbott N; Zhang YY; Summers J
    J Virol; 2001 Oct; 75(20):9623-32. PubMed ID: 11559794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron microscopic studies on duck hepatitis B virus particles in hepatocytes and sequential changes in various patterns of infection.
    Okinaga S; Fukuda R; Fukumoto S; Shimada Y
    Gastroenterol Jpn; 1991 Aug; 26(4):458-64. PubMed ID: 1916154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
    Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
    Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver.
    Barraud L; Douki T; Guerret S; Chevallier M; Jamard C; Trepo C; Wild CP; Cadet J; Cova L
    Cancer Detect Prev; 2001; 25(2):192-201. PubMed ID: 11341355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes.
    Saade F; Buronfosse T; Guerret S; Pradat P; Chevallier M; Zoulim F; Jamard C; Cova L
    J Viral Hepat; 2013 Apr; 20(4):e56-65. PubMed ID: 23490390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks.
    Cova L; Wild CP; Mehrotra R; Turusov V; Shirai T; Lambert V; Jacquet C; Tomatis L; Trépo C; Montesano R
    Cancer Res; 1990 Apr; 50(7):2156-63. PubMed ID: 2107970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.